Page last updated: 2024-11-07

5-bromotryptophan

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth

Description

5-bromotryptophan: RN given refers to (DL)-isomer; RN for cpd without isomeric designation not available 1/91; structure given in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

5-bromotryptophan : A non-proteinogenic alpha-amino acid that is tryptophan in which the hydrogen at position 5 on the indole ring is replaced by a bromo group. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID644329
CHEMBL ID320227
SCHEMBL ID454983
MeSH IDM0182763

Synonyms (26)

Synonym
l-tryptophan, 5-bromo- (9ci)
25197-99-3
5-bromo-l-tryptophan
l-tryptophan, 5-bromo-
5-bromo-tryptophan
tryptophan, 5-bromo-, l- (8ci)
5-bromotryptophan
CHEMBL320227
(2s)-2-amino-3-(5-bromo-1h-indol-3-yl)propanoic acid
(s)-2-amino-3-(5-bromo-1h-indol-3-yl)propanoic acid
AKOS016003655
SCHEMBL454983
tryptophan, 5-bromo-
CS-B1055
5brw
mfcd06796707
(s)-2-amino-3-(5-bromo-1h-indol-3-yl)propanoicacid
KZDNJQUJBMDHJW-VIFPVBQESA-N
DS-17331
A1-29369
A877670
EN300-6472318
DTXSID201315301
HY-20897A
64X ,
PD171415
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Bioassays (1)

Assay IDTitleYearJournalArticle
AID220533Inhibitory activity against aggregation of deoxy-HbS using CSAT assay1990Journal of medicinal chemistry, Dec, Volume: 33, Issue:12
Hemoglobin S antigelation agents based on 5-bromotryptophan with potential for sickle cell anemia.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (5)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's4 (80.00)18.2507
2000's1 (20.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other5 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]